Skip to Content Facebook Feature Image

Advice to feed babies peanuts early and often helped thousands of kids avoid allergies

ENT

Advice to feed babies peanuts early and often helped thousands of kids avoid allergies
ENT

ENT

Advice to feed babies peanuts early and often helped thousands of kids avoid allergies

2025-10-21 21:46 Last Updated At:21:50

A decade after a landmark study proved that feeding peanut products to young babies could prevent development of life-threatening allergies, new research finds the change has made a big difference in the real world.

Peanut allergies began to decline in the U.S. after guidance first issued in 2015 upended medical practice by recommending introducing the allergen to infants starting as early as 4 months. The rate of peanut allergies in children ages 0 to 3 fell by more than 27% after guidance for high-risk kids was first issued in 2015, and by more than 40% after the recommendations were expanded in 2017.

“That’s a remarkable thing, right?” said Dr. David Hill, an allergist and researcher at Children’s Hospital of Philadelphia, and author of a study published Monday in the medical journal Pediatrics. Hill and colleagues analyzed electronic health records from dozens of pediatric practices to track diagnoses of food allergies in young children before, during and after the guidelines were issued.

“I can actually come to you today and say there are less kids with food allergy today than there would have been if we hadn't implemented this public health effort,” he added.

About 60,000 children have avoided food allergies since 2015, including 40,000 children who otherwise would have developed peanut allergies. Still, about 8% of children are affected by food allergies, including more than 2% with a peanut allergy.

Peanut allergy is caused when the body’s immune system mistakenly identifies proteins in peanuts as harmful and releases chemicals that trigger allergic symptoms, including hives, respiratory symptoms and, sometimes, life-threatening anaphylaxis.

For decades, doctors had recommended delaying feeding children peanuts and other foods likely to trigger allergies until age 3. But in 2015, Gideon Lack at King’s College London, published the groundbreaking Learning Early About Peanut Allergy, or LEAP, trial.

Lack and colleagues showed that introducing peanut products in infancy reduced the future risk of developing food allergies by more than 80%. Later analysis showed that the protection persisted in about 70% of kids into adolescence.

The study immediately sparked new guidelines urging early introduction of peanuts — but putting them into practice has been slow.

Only about 29% of pediatricians and 65% of allergists reported following the expanded guidance issued in 2017, surveys found.

Confusion and uncertainty about the best way to introduce peanuts early in life led to the lag, according to a commentary that accompanied the study. Early on, medical experts and parents alike questioned whether the practice could be adopted outside of tightly controlled clinical settings.

The data for the analysis came from a subset of participating practice sites and may not represent the entire U.S. pediatric population, noted the commentary, led by Dr. Ruchi Gupta, a child allergy expert at Northwestern University.

However, the new research offers “promising evidence that early allergen introduction is not only being adopted but may be making a measurable impact,” the authors concluded.

Advocates for the 33 million people in the U.S. with food allergies welcomed signs that early introduction of peanut products is catching on.

“This research reinforces what we already know and underscores a meaningful opportunity to reduce the incidence and prevalence of peanut allergy nationwide,” said Sung Poblete, chief executive of the nonprofit group Food Allergy Research & Education, or FARE.

The new study emphasizes the current guidance, updated in 2021, which calls for introducing peanuts and other major food allergens between four and six months, without prior screening or testing, Hill said. Parents should consult their pediatricians about any questions.

“It doesn’t have to be a lot of the food, but little tastes of peanut butter, milk-based yogurt, soy-based yogurts and tree butters,” he said. “These are really good ways to allow the immune system exposure to these allergenic foods in a safe way.”

Tiffany Leon, 36, a Maryland registered dietitian and director at FARE, introduced peanuts and other allergens early to her two young sons.

At first, Leon’s own mother was shocked at the advice to feed babies such foods before the age of 3, she said. But Leon explained how the science had changed.

“As a dietitian, I practice evidence-based recommendations,” she said. “So when someone told me, ‘This is how it’s done now, these are the new guidelines,’ I just though, OK, well, this is what we’re going to do.”

This story has been corrected to report that about 40,000 children have avoided peanut allergies after doctors began recommending introducing the peanuts to babies, not 60,000.

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

FILE - An arrangement of peanuts is seen Feb. 20, 2015, in New York. (AP Photo/Patrick Sison, File)

FILE - An arrangement of peanuts is seen Feb. 20, 2015, in New York. (AP Photo/Patrick Sison, File)

NEW YORK--(BUSINESS WIRE)--May 22, 2026--

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Coty Inc. (“Coty” or the “Company”) (NYSE: COTY) and reminds investors of the May 22, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522537290/en/

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose the true state of Coty’s slowing growth in the beauty market, notably, the Consumer Beauty market was underperforming, margins were compressed by increased marketing investments and there was slowing growth in its Prestige fragrance segment. Such statements absent these material facts caused Plaintiff and other shareholders to purchase Coty’s securities at artificially inflated prices.

After the market closed on February 4 and 5, 2026, Coty announced its financial results for the second quarter fiscal year 2026, unveiling disappointing earnings results with worsening performance in the Consumer Beauty segment. The Company also noted the recent transition of its Chief Executive Officer in conjunction with the below-expectation results. Coty further withdrew its fiscal year 2026 guidance for EBITDA and revised the Company’s near-term outlook downward. Coty attributed its results and lowered guidance to a combination of macroeconomic factors including rising costs and uncertain consumer demand and lack of “operational discipline” in both Prestige and Consumer Beauty segments.

Investors and analysts reacted immediately to Coty’s revelation. The price of Coty’s common stock declined from a closing market price of $3.43 per share on February 4, 2026, to $2.66 per share on February 6, 2026, a decline of about 22%.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding Coty’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

To learn more about the Coty class action, go to www.faruqilaw.com/COTY or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Follow us for updates on LinkedIn, on X, or on Facebook.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

COTY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Coty (COTY) Investors of Securities Class Action Deadline on May 22, 2026

COTY FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Coty (COTY) Investors of Securities Class Action Deadline on May 22, 2026

Recommended Articles